Batavia Biosciences
Leiden
About Batavia Biosciences
Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product candidates from discovery to the clinic with improved success and lower cost. Our services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. Batavia Biosciences has successfully worked on viral and bacterial vaccines, recombinant proteins, antibodies and gene therapy products. Unique technologies such as STEP® protein expression technology and SCOUT® high throughput process technology accelerate timelines and reduce costs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $8.0M
- Funding stage: M&A
- Last round: Grant (Apr 2024)
- Website: bataviabiosciences.com
- Phone: +310889950600
Industries & Categories
Biotechnology, Genetics, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/batavia-biosciences-37564 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.